The Phoenix has helped the Autodesk-backed manufacturing analytics technology provider raise $24m in an extended series B round.
Author: Jordan Williams
DZS closes Rift acquisition deal
Intel Capital has exited the cloud network orchestration and automation software provider, which has been bought by DZS.
Houmo.ai handles Lenovo funding
Lenovo Capital participated in the first round to be disclosed by the artificial intelligence technology developer, which raised an undisclosed amount.
Nextmarkets nabs $30m
The Axel Springer-backed share trading platform developer secured $30m that will fund platform development and customer acquisition.
TytoCare hikes series D up to $100m
The medical examination software provider doubled the size of a round that includes Qualcomm Ventures along with its valuation.
Cashify calls in $15m
The Aihuishou-backed second-hand electronics platform operator has raked in new financing from an Olympus Capital subsidiary.
Netease helps Theorycraft assemble launch funding
Netease has led a $37.5m round disclosed by multiplayer game developer Theorycraft Games as it emerged from stealth.
Yugabyte records $48m round
The database platform developer will embark on international expansion with funding raised from investors including Dell Technologies Capital and Wipro Ventures.
Asuragen awaits results of $320m Bio-Techne acquisition
Merck & Co is set to exit the genomic services and cancer diagnostics provider in an acquisition by Bio-Techne potentially sized at $320m.
MoneyLion devours WTI in acquisition deal
The financial planning technology developer has been bought by MoneyLion just over a year after raising money from NFP Global.
Telus pops into PocketPills’ series B
Telus’ corporate venturing unit has led a $23.7m round for the Canadian online pharmacy as it seeks to take its coverage nationwide.
Reflexion raises series D round to $150m
The Pfizer and Johnson & Johnson-backed cancer treatment developer is eyeing expansion in Asia after receiving $40m in additional series D funding.
Kaltura calls in $100m IPO filing
The Mitsui and Intel-backed cloud video platform developer has filed to go public having last raised money five years ago.
Pear Therapeutics extends series D to $100m
An unnamed care provider has added $20m to the $80m the software-based therapeutics developer received from investors including Novartis and SoftBank in December.